Evidence map›Paper›PMID 35366830›Full record

ArticleBMC pregnancy and childbirth2022

Serum anti-Müllerian hormone levels are associated with early miscarriage in the IVF/ICSI fresh cycle.

Xin Liu, Ying Han, Xinyan Wang, Yunshan Zhang, Aijun Du, Ruqiang Yao, Jiabei Lv, Haining Luo

Open access · goldAbstract read
In one paragraph

Article in BMC pregnancy and childbirth, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Xin LiuCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China.
Ying HanCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China.
Xinyan WangCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China.
Yunshan ZhangCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China.
Aijun DuCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China.
Ruqiang YaoCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China.
Jiabei LvCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China.
Haining LuoCentre for Reproductive Medicine, Tianjin Central Hospital of Gynecology Obstetrics, No. 156 Nankai San Ma Road, Tianjin, 300100, China. luohn163@163.com.
Tianjin Central Hospital of Gynecology Obstetrics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnti-Müllerian hormone (AMH) is used as a biomarker to estimate ovarian reserve. The relationship between AMH and early miscarriage of in vitro fertilization (IVF) is still inconclusive. This study aimed to explore whether serum AMH levels are associated with early miscarriage rates after in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) with fresh embryo transfer (ET).

methodsThis retrospective cohort study included 2246 patients undergoing their first oocyte retrievals for IVF/ICSI with fresh embryos transferred to Tianjin Central Hospital of Gynecology Obstetrics between May 2018 and March 2020. The serum AMH levels of the patients were measured within 12 months before the IVF/ICSI cycles. All women were divided into a low-AMH group, medium-AMH group and high-AMH group. Binary logistic regression was applied to confirm whether the serum AMH level was associated with the risk of early miscarriage independent of potential confounders, such as age, body mass index (BMI), duration of infertility, main diagnosis, history of internal medicine diseases, number of oocytes retrieved and high-quality embryo rate.

resultsThe early miscarriage rate was significantly lower in the medium-AMH group than in either the low-AMH or high-AMH group among young (< 35 years) women (P = 0.015). In women above 35 years of age, the early miscarriage rates in the three AMH groups were not significantly different. Young women with high serum AMH levels had a significantly higher risk of early miscarriage regardless of age or other potential confounders (adjusted odds ratio (OR) 2.382, 95% confidence interval (CI) 1.246 to 4.553, P = 0.009). The results remained similar after restricting the analysis to women without polycystic ovary syndrome (PCOS).

conclusionsWith a high AMH level, young women had a higher risk of early miscarriage than women with a medium AMH level in their first IVF/ICSI treatment. In young women, serum AMH levels were independently associated with the risk of early miscarriage after IVF-ET treatment. Serum AMH levels might be a valuable marker to estimate the risk of early miscarriage. It is worth noting to the clinical value of AMH.

Indexed as

Abortion, SpontaneousAnti-Mullerian HormoneFemaleFertilization in VitroHumansPregnancyRetrospective StudiesSperm Injections, IntracytoplasmicAnti-Mullerian HormoneAnti-Müllerian hormoneEarly miscarriageIVF/ICSIPregnancy rate

Identifiers

PMID35366830
PMCPMC8976292
OpenAlexW4225244125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.